Reply to Zuo et al

Affiliations

Comment

Stefanie Kulnigg-Dabsch et al. Inflamm Bowel Dis. 2013 Oct.

. 2013 Oct;19(11):E85-6.

doi: 10.1097/MIB.0b013e3182a508b1.

¹ Department of Medicine 3, Divison of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria.

No abstract available

Comment on

Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial.
Kulnigg-Dabsch S, Schmid W, Howaldt S, Stein J, Mickisch O, Waldhör T, Evstatiev R, Kamali H, Volf I, Gasche C. Kulnigg-Dabsch S, et al. Inflamm Bowel Dis. 2013 Jul;19(8):1609-16. doi: 10.1097/MIB.0b013e318281f4db. Inflamm Bowel Dis. 2013. PMID: 23644823 Clinical Trial.
Iron deficiency generates secondary thrombocytosis and platelet activation in inflammatory bowel disease : the randomized, controlled ThromboVIT trial.
Zuo L, Li Y, Wang H, Zhu W. Zuo L, et al. Inflamm Bowel Dis. 2013 Oct;19(11):E85. doi: 10.1097/MIB.0b013e3182a50899. Inflamm Bowel Dis. 2013. PMID: 23962897 No abstract available.